These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6132792)

  • 81. Malathion A and B esterases of mouse liver--II. Effect of EPN in vitro and in vivo.
    Bhagwat VM; Ramachandran BV
    Biochem Pharmacol; 1975 Sep; 24(18):1727-9. PubMed ID: 1191330
    [No Abstract]   [Full Text] [Related]  

  • 82. Ecotoxicology of phenylphosphonothioates.
    Francis BM; Hansen LG; Fukuto TR; Lu PY; Metcalf RL
    Environ Health Perspect; 1980 Jun; 36():187-95. PubMed ID: 6159210
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Toxicokinetics of a single 50 mg/kg oral dose of [2,3-14C]acrylamide in White Leghorn hens.
    Blumenthal GM; Abdel-Rahman AA; Wilmarth KR; Friedman MA; Abou-Donia MB
    Fundam Appl Toxicol; 1995 Aug; 27(1):149-53. PubMed ID: 7589925
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Stimulation of detoxification of O-94-nitrophenyl) phenylphosphonothioate (EPN) by nikethamide and phenobarbital.
    DuBois KP; Kinoshita F
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):59-62. PubMed ID: 5902955
    [No Abstract]   [Full Text] [Related]  

  • 85. Disposition, pharmacokinetics, and metabolism of 14C-fotemustine in cancer patients.
    Ings RM; Gray AJ; Taylor AR; Gordon BH; Breen M; Hiley M; Brownsill R; Marchant N; Richards R; Wallace D
    Eur J Cancer; 1990; 26(7):838-42. PubMed ID: 2145908
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparative studies on the inhibition of liver amidases, aminopeptidase and serum cholinesterases by EPN.
    Sato T; Moroi K
    Toxicol Appl Pharmacol; 1973 Aug; 25(4):553-9. PubMed ID: 4741776
    [No Abstract]   [Full Text] [Related]  

  • 87. PROTECTIVE ACTION BY THIOURACIL AGAINST THE ACUTE TOXICITY IN MICE OF O-ETHYL O-(4-NITROPHENYL) PHENYLPHOSPHONOTHIOATE (EPN).
    KELEMEN MH; VOLLE RL
    Toxicol Appl Pharmacol; 1965 May; 7():418-24. PubMed ID: 14291880
    [No Abstract]   [Full Text] [Related]  

  • 88. New Synthesis of Optically Active O-Aryl O-Ethyl Phenylphosphonothionates.
    Yoshikawa H
    Biosci Biotechnol Biochem; 1999; 63(2):424-6. PubMed ID: 27393069
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Disposition of 14C-cefatrizine in man.
    Gaver RC; Deeb G
    Drug Metab Dispos; 1980; 8(3):157-62. PubMed ID: 6104579
    [No Abstract]   [Full Text] [Related]  

  • 90. The sustained release of pyrimethamine base or pyrimethamine pamoate from a biodegradable injectable depot preparation in mice.
    Coleman MD; Mihaly GW; Ward SA; Edwards G; Howells RE; Breckenridge AM
    J Pharm Pharmacol; 1985 Dec; 37(12):878-83. PubMed ID: 2868095
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The disposition of DL-3-di-n-butylamino-1-[2,6-bis(4-trifluoromethylphenyl)-4-pyridyl] propanol methanesulfonate in mice.
    Chung H; Jimmerson VR; Sanders JE; Bounds DW; Rozman RS; Thorne J
    Drug Metab Dispos; 1981; 9(1):65-6. PubMed ID: 6111435
    [No Abstract]   [Full Text] [Related]  

  • 92. [Metabolism of 6-amino-2-methyl-3-o-tolyl-4(3H)-quinazolinone. Formation of glycolic acid amide as detoxication reaction].
    Hoffter D
    Arzneimittelforschung; 1971 Apr; 21(4):505-9. PubMed ID: 5108151
    [No Abstract]   [Full Text] [Related]  

  • 93. Studies of the toxicity and of the enzyme kinetics of ethyl p-nitrophenyl thionobenzene phosphonate (EPN).
    HODGE HC; MAYNARD EA; HURWITZ L; DISTEFANO V; DOWNS WL; JONES CK; BLANCHET HJ
    J Pharmacol Exp Ther; 1954 Sep; 112(1):29-39. PubMed ID: 13192606
    [No Abstract]   [Full Text] [Related]  

  • 94. Pharmacokinetics and metabolism of a topically applied dose of O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphonothioate in hens.
    Abou-Donia MB
    Toxicol Appl Pharmacol; 1979 Nov; 51(2):311-28. PubMed ID: 93793
    [No Abstract]   [Full Text] [Related]  

  • 95. Pharmacokinetics and metabolism of a single subneurotoxic oral dose of tri-o-cresyl phosphate in hens.
    Suwita E; Abou-Donia MB
    Arch Toxicol; 1990; 64(3):237-41. PubMed ID: 2372235
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Physiological disposition and metabolism of O-ethyl-O-4-nitrophenyl phenylphosphonothioate in male cats following a single dermal administration.
    Abou-Donia MB; Kinnes CG; Abdo KM; Bjornsson TD
    Drug Metab Dispos; 1983; 11(1):31-6. PubMed ID: 6132792
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The absorption, distribution, excretion, and metabolism of a single oral dose of O-ethyl O-4-nitrophenyl phenylphosphonothioate in hens.
    Abou-Donia MB; Reichert BL; Ashry MA
    Toxicol Appl Pharmacol; 1983 Aug; 70(1):18-28. PubMed ID: 6612735
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Disposition, elimination and metabolism of O-ethyl O-4-nitrophenyl phenylphosphonothioate after subchronic dermal application in male cats.
    Abou-Donia MB; Sivarajah K; Abou-Donia SA
    Toxicology; 1983 Feb; 26(2):93-111. PubMed ID: 6857694
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Distribution and metabolism of O-ethyl O-4-nitrophenyl phenylphosphonothioate after a single oral dose in one-week old chicks.
    Abou-Donia MB; Hernandez YM; Ahmed NS; Abou-Donia SA
    Arch Toxicol; 1983 Sep; 54(1):83-96. PubMed ID: 6639355
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.